Pharmaceutical market share Saudi Arabia H1 2024, by area of therapy

Published by Salma Saleh, Nov 21, 2024

As of the first half of 2024, diabetes held the largest share of the private therapeutic private market in Saudi Arabia. SPIMACO was the second leading company in the diabetes therapeutic market with four percent of the market. The six therapeutic areas accounted for 54 percent of the total private pharmaceutical market.

Pharmaceutical market share in Saudi Arabia as of H1 2024, by area of therapy

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

August 2024

Region

Saudi Arabia

Survey time period

2024

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Pharmaceutical industry in Germany "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Pharmaceutical industry in Germany

Overview

7

Market figures

7

Pharmacies

6

Medical products

8

Leading pharmaceutical companies

8

Development and research

8

Further Content: You might find this interesting as well

Topics

SanofiGlobal pharmaceutical industryTop pharmaceutical drugsPfizerNovartis
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.